PODD vs ULS · P/E 34, rev $2.07B vs P/E 55, rev $2.87B
Insulet Corporation (PODD) versus UL Solutions Inc. (ULS) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
UL Solutions Inc. (ULS) is a specialty business services company listed on NYSE.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported ULS revenue for 2024-12-31 was $2.87B. Net income was $345.0M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. ULS currently screens at market cap $18.97B and trailing P/E 54.7.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. ULS currently screens at market cap $18.97B and trailing P/E 54.7.
Not investment advice. Open the PODD and ULS stock pages for the full models.
Not investment advice.